Search Within

Martin Stuart Tallman

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (13)
  3. Correspondence (1)
  4. Research Letter (1)
Groups
  1. Adult Leukemia (33)
  2. Center for Hematologic Malignancies (33)
  3. Department of Medicine (33)
  4. Hematologic Malignancies, Division of (33)
  5. Population Sciences Research Program (33)
  6. Biostatistics Service (31)

More Groups

People
  1. Andriy Derkach (20)
  2. Ross Levine (19)
  3. Christopher Famulare (13)
  4. Eytan Stein (13)
  5. Maria Arcila (13)
  6. Aaron Goldberg (12)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (4)
  5. 2021 (6)
  6. 2020 (8)

More Years

Publications
  1. Blood (15)
  2. Blood Advances (4)
  3. Leukemia and Lymphoma (4)
  4. Leukemia Research (3)
  5. American Journal of Hematology (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (19)
  2. Taylor & Francis Group (4)
  3. Elsevier Ltd (3)
  4. American Association for Cancer Research (2)
  5. John Wiley & Sons, Inc. (2)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naìˆve acute lymphoblastic leukemia
    Correspondence

    Gaulin, C.; Chan, A.; Derkach, A.; Park, J. H.; Mantha, S.; Geyer, M. B.; Tallman, M. S.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
    Journal Article

    Ball, B. J.; Famulare, C. A.; Stein, E. M.; Tallman, M. S.; Derkach, A.; Roshal, M.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
    Journal Article

    Taylor, J.; Haddadin, M.; Upadhyay, V. A.; Grussie, E.; Mehta-Shah, N.; Brunner, A. M.; Louissaintr, A. Jr; Lovitch, S. B.; Dogan, A.; Fathi, A. T.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes
    Journal Article

    Coombs, C. C.; Zehir, A.; Devlin, S. M.; Kishtagari, A.; Syed, A.; Jonsson, P.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; more...
    Cell Stem Cell (2017)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis in patients with advanced cancer
    Meeting Abstract

    Zehir, A.; Coombs, C. C.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; Arcila, M. E.; Tallman, M. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Mutational analysis of clonal hematopoiesis in solid tumor patients illustrates the critical role of systemic anti-cancer therapies in the evolution of somatic leukemia disease alleles
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; Arcila, M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Next-generation sequencing of matched normal blood identifies clonal hematopoiesis in a significant subset of solid tumor patients without hematologic malignancies
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Middha, S.; Cheng, D.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies
    Meeting Abstract

    Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
    Blood (2014)

    Fulltext@MSK | Save